Cargando…
Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice
Diabetic cardiomyopathy is characterized by abnormal myocardial structure or performance in the absence of coronary artery disease or significant valvular heart disease in patients with diabetes mellitus. The spectrum of diabetic cardiomyopathy ranges from subtle myocardial changes to myocardial fib...
Autores principales: | Hsuan, Chin-Feng, Teng, Sean I. F., Hsu, Chih-Neng, Liao, Daniel, Chang, Allen Jiun-Wei, Lee, Hsiao-Lin, Hee, Siow-Wey, Chang, Yi-Cheng, Chuang, Lee-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045486/ https://www.ncbi.nlm.nih.gov/pubmed/36979641 http://dx.doi.org/10.3390/biomedicines11030662 |
Ejemplares similares
-
Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism
por: Hsu, Chih-Neng, et al.
Publicado: (2023) -
T helper 17 cells: A new actor on the stage of type 2 diabetes and aging?
por: Chang, Yi‐Cheng, et al.
Publicado: (2021) -
Prolonged Induction Activates Cebpα Independent Adipogenesis in NIH/3T3 Cells
por: Shao, Hsiao-Yun, et al.
Publicado: (2013) -
The Role of Organelle Stresses in Diabetes Mellitus and Obesity: Implication for Treatment
por: Chang, Yi-Cheng, et al.
Publicado: (2015) -
ER ribosomal-binding protein 1 regulates blood pressure and potassium homeostasis by modulating intracellular renin trafficking
por: Chiu, Chu-Hsuan, et al.
Publicado: (2023)